NeoGenomics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
NeoGenomics, Inc. (NEO) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $29.98 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-07-28
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $29.98M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $29.98M.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $30.53M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $30.53M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $29.98M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $29.98M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $30.53M 10-K · filed 2026-02-17 |
| 2025-09-30 | $30.53M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $30.53M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $33.31M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $33.34M 10-K · filed 2025-02-18 |
| 2024-09-30 | $33.34M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $33.34M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $33.34M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $33.45M 10-K · filed 2024-02-20 |
| 2023-09-30 | $33.45M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $33.45M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $33.45M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $35.13M 10-K · filed 2023-02-24 |
| 2022-09-30 | $33.96M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $33.96M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $33.90M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $33.90M 10-K · filed 2022-02-25 |
| 2021-09-30 | $33.90M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $34.65M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $9.83M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $9.83M 10-K · filed 2021-02-25 |
| 2020-09-30 | $9.87M 10-Q · filed 2020-10-29 |
| 2019-12-31 | $9.29M 10-K · filed 2020-02-28 |
| 2018-12-31 | $10.11M 10-K · filed 2019-02-26 |
| 2017-12-31 | $5.68M 10-K · filed 2018-03-13 |
| 2016-12-31 | $6.89M 10-K · filed 2017-03-14 |
| 2016-09-30 | $7.26M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $7.26M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $7.26M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $7.27M 10-K · filed 2016-04-18 |
| 2015-09-30 | $372.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $372.00K 10-Q · filed 2015-07-31 |
| 2015-03-31 | $371.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $371.00K 10-K · filed 2015-03-03 |
| 2014-09-30 | $366.00K 10-Q · filed 2014-11-04 |
| 2014-06-30 | $223.00K 10-Q · filed 2014-07-29 |
| 2014-03-31 | $223.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $223.00K 10-K · filed 2014-02-24 |
| 2013-09-30 | $223.00K 10-Q · filed 2013-10-30 |
| 2013-06-30 | $223.00K 10-Q · filed 2013-08-02 |
| 2013-03-31 | $223.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $223.00K 10-K · filed 2013-02-21 |
| 2012-09-30 | $223.00K 10-Q · filed 2012-11-05 |
| 2012-06-30 | $223.00K 10-Q/A · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |